课题基金 / 基金详情

Functional Analysis of Activins During Development

Functional Analysis of Activins During Development
发育过程中激活蛋白的功能分析
批准号:
7213231
负责人:
MARTIN M. MATZUK
金额:
$32.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-08-17 至 2009-03-31
关键词:
ACVR2 geneACVR2B geneAblationActivinsAdultApoptosisAppendixBMP4BMP7 geneBMPR2 geneBindingBinding ProteinsBiochemicalBiologicalBirthBone Morphogenetic ProteinsCell NucleusComplexDataDefectDevelopmentDifferentiation and GrowthDiseaseEmbryoExencephaliesFamilyFamily memberFemaleFertilityFollicle Stimulating HormoneFollistatinGDF9 geneGene ExpressionGene Expression ProfileGenerationsGenesGeneticGenetic ModelsGrantGrowthGrowth Differentiation Factor 9Growth FactorHeart failureHeterodimerizationHeterozygoteHomozygoteHourHumanIn VitroIndividualInfertilityKnock-outKnockout MiceLaboratoriesLeftLifeLigandsLiverMADH2 geneMADH3 geneMADH4 geneMADH6 geneMADH7 geneMalignant neoplasm of ovaryMammalsManuscriptsMediatingMeiosisModelingMusMuscleMutant Strains MiceMutateMutationNewborn InfantOocytesOvarianOvarian Granulosa CellOvaryPathway interactionsPhenotypePhosphorylationPhysiological ProcessesPhysiologyPlayPolycystic Ovary SyndromePremature Ovarian FailureProteinsReceptor ActivationReceptor Serine/Threonine KinaseReproductionReproductive PhysiologyResearch PersonnelRoleSecondary toSignal PathwaySignal TransductionSignaling ProteinSkinStagingStructure of primordial sex cellSystemTacrolimus Binding ProteinsTestingTissuesTransforming Growth Factor betaTransforming Growth FactorsTransgenic MiceTransgenic ModelType II Activin ReceptorsVentricularWomanactivin Aactivin Bbasebody systembone morphogenetic protein receptor type Ibone morphogenetic protein receptor type IIcell growthcell typecraniofacialdosageextracellularfolliculogenesisgene functiongranulosa cellin vivoinhibinintraovarianmalemouse modelpostnatalprogramsreceptorreceptor bindingrecombinasereproductiveresponsetooltranscription factor

项目摘要

项目成果

MARTIN M. MATZUK的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The transforming growth factor beta (TGFbeta) superfamily is the largest family of secreted proteins in mammals. This family includes the activins, inhibins, TGFbetas, bone morphogenetic proteins (BMPs), and growth differentiation factors (GDFs). These ligands signal through an oligomeric complex of transmembrane type I and type II serine/threonine kinase receptors. Ligand-induced heterodimerization of these receptors leads to phosphorylation of receptor-regulated SMAD proteins, which translocate to the nucleus with the common SMAD4 protein and regulate gene expression. The characterization of mice and humans with mutations in these signaling pathways has revealed the diversity of developmental and physiological processes in which this family functions. Through the support of this grant, my laboratory has generated and analyzed mice with mutations in activin subunits, an activin binding protein (follistatin), activin receptor type II, a downstream receptor binding protein (FKBP 12), and SMADS. We have recently shown that mice with granulosa cell ablation of follistatin are a model for premature ovarian failure in women. The utility of these knockout mice in defining gene function in vivo is unparalleled, and these powerful genetic models have been indispensable for investigating development and reproduction. The overall hypothesis of this R01 renewal is that we will be able to dissect the TGFbeta signaling pathways in the ovary using available and newly-created ovary-specific knockout mouse models. These studies will allow us to place ligands, receptors, and downstream SMAD proteins into biological pathways in a single cell type (i.e., The granulosa cells of the ovary). The Specific Aims of the proposed studies are as follows: 1) Produce transgenic models to define the intraovarian roles of activins; 2) Dissect the activin receptor type II, BMP receptor type II, and BMP receptor type I signaling pathways in the ovary; and 3) Study the interrelationships of the downstream SMAD proteins in ovarian physiology. Generation and characterization of these transgenic mice will define essential and interacting TGFa superfamily signaling components and pathways in the ovary and will continue to be important models for human reproductive diseases including infertility, premature ovarian failure, polycystic ovary syndrome, and ovarian cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Kinases as Therapeutic Targets for Endometriosis
  • 批准号:
    10674987
  • 项目类别:
  • 资助金额:
    $68.77万
  • 财政年份:
    2022
  • 负责人:
    MARTIN M. MATZUK
  • 依托单位:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
  • 批准号:
    10682061
  • 项目类别:
  • 资助金额:
    $64.52万
  • 财政年份:
    2022
  • 负责人:
    MARTIN M. MATZUK
  • 依托单位:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
  • 批准号:
    10764639
  • 项目类别:
  • 资助金额:
    $4.84万
  • 财政年份:
    2022
  • 负责人:
    MARTIN M. MATZUK
  • 依托单位:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
  • 批准号:
    10419647
  • 项目类别:
  • 资助金额:
    $10.15万
  • 财政年份:
    2022
  • 负责人:
    MARTIN M. MATZUK
  • 依托单位: